US Stock MarketDetailed Quotes
NUTX Nutex Health
- 32.9100
- +1.0200+3.20%
Close Nov 22 16:00 ET
- 31.2700
- -1.6400-4.98%
Post 20:01 ET
178.93MMarket Cap-3584P/E (TTM)
33.0900High31.4800Low23.42KVolume32.1900Open31.8900Pre Close752.74KTurnover0.72%Turnover RatioLossP/E (Static)5.44MShares38.715052wk High2.96P/B107.52MFloat Cap4.160052wk Low--Dividend TTM3.27MShs Float7920.0000Historical High--Div YieldTTM5.05%Amplitude4.1600Historical Low32.1350Avg Price1Lot Size
Nutex Health Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 25.62%78.79M | 29.12%76.08M | 19.75%67.45M | 12.93%247.65M | 29.68%69.67M | 120.89%62.72M | 1.51%58.92M | -28.81%56.33M | -33.85%219.29M | -15.26%53.72M |
| Operating revenue | 25.62%78.79M | 29.12%76.08M | 19.75%67.45M | 12.93%247.65M | 29.68%69.67M | 120.89%62.72M | 1.51%58.92M | -28.81%56.33M | -33.85%219.29M | -15.26%53.72M |
| Cost of revenue | 2.19%56.88M | 8.61%53.52M | 11.30%57.3M | 4.41%212.87M | -1.03%56.46M | 6.81%55.66M | -4.15%49.28M | 18.86%51.48M | 33.91%203.87M | 29.89%57.04M |
| Gross profit | 210.16%21.92M | 133.87%22.56M | 109.52%10.16M | 125.49%34.77M | 498.14%13.21M | 129.80%7.07M | 45.33%9.65M | -86.46%4.85M | -91.40%15.42M | -117.03%-3.32M |
| Operating expense | 50.80%11.83M | 5.81%10.59M | -6.30%8.71M | 81.41%36.28M | 271.39%9.14M | 14.80%7.84M | 142.32%10.01M | 41.30%9.29M | 266.15%20M | 523.42%2.46M |
| Selling and administrative expenses | 50.80%11.83M | 5.81%10.59M | -4.05%8.71M | 80.33%36.07M | 271.39%9.14M | 14.80%7.84M | 142.32%10.01M | 38.00%9.08M | 266.15%20M | 523.42%2.46M |
| -General and administrative expense | 50.80%11.83M | 5.81%10.59M | -4.05%8.71M | 80.33%36.07M | 271.39%9.14M | 14.80%7.84M | 142.32%10.01M | 38.00%9.08M | 266.15%20M | 523.42%2.46M |
| Other operating expenses | ---- | ---- | ---- | --217.27K | --0 | ---- | ---- | --217.27K | ---- | ---- |
| Operating profit | 1,397.05%10.09M | 3,401.75%11.97M | 132.61%1.45M | 67.05%-1.51M | 170.54%4.08M | 97.45%-777.76K | -114.46%-362.54K | -115.20%-4.45M | -102.63%-4.58M | -130.27%-5.78M |
| Net non-operating interest income expense | -31.30%-5.38M | -4.37%-5.05M | -41.54%-4.44M | -30.64%-16.32M | -48.02%-4.24M | -20.44%-4.1M | -10.83%-4.84M | -69.19%-3.14M | -101.59%-12.49M | -47.17%-2.86M |
| Non-operating interest expense | 31.30%5.38M | 4.37%5.05M | 41.54%4.44M | 30.64%16.32M | 48.02%4.24M | 20.44%4.1M | 10.83%4.84M | 69.19%3.14M | 101.59%12.49M | 47.17%2.86M |
| Other net income (expense) | -74,904.13%-7.29M | -2,537.85%-3.01M | 1,248.47%2.84M | 92.38%-30.66M | -14,281.46%-30.55M | 100.00%9.74K | 104.98%123.53K | 89.61%-247.46K | -21,646.46%-402.58M | 94.41%-212.43K |
| Gain on sale of security | ---6.73M | --3.06M | --2.6M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Special income (charges) | -878.33%-425.22K | ---6.67M | ---- | 92.47%-30.26M | ---30.22M | 99.99%-43.46K | --0 | ---- | -11,212.69%-402.02M | --0 |
| -Less：Restructuring and merger&acquisition | --0 | ---- | ---- | -98.88%43.46K | --0 | --43.46K | ---- | ---- | 9.34%3.89M | --0 |
| -Less:Impairment of capital assets | --0 | --3.2M | ---- | -92.41%30.22M | --30.22M | --0 | --0 | ---- | --398.14M | --0 |
| -Write off | --425.22K | --3.47M | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Other non- operating income (expenses) | -341.79%-128.65K | 385.32%599.5K | 197.47%241.19K | 28.63%-399.18K | -54.62%-328.46K | -91.56%53.21K | -91.20%123.53K | 89.61%-247.46K | -110.32%-559.3K | 13.11%-212.43K |
| Income before tax | 46.97%-2.58M | 176.82%3.9M | 98.05%-152.82K | 88.44%-48.49M | -246.87%-30.71M | 98.87%-4.87M | -16.97%-5.08M | -131.33%-7.83M | -347.59%-419.65M | -166.33%-8.85M |
| Income tax | 1,439.49%4.58M | 209.60%893.89K | 142.79%389.67K | -138.71%-5.07M | -266.11%-3M | 95.99%-342.26K | -104.15%-815.61K | -616.47%-910.66K | 1,255.54%13.09M | 1,529.91%1.81M |
| Net income | -58.38%-7.17M | 170.56%3.01M | 92.16%-542.49K | 89.97%-43.42M | -159.99%-27.71M | 98.93%-4.52M | 82.22%-4.27M | -127.88%-6.92M | -356.78%-432.74M | -179.10%-10.66M |
| Net income continuous Operations | -58.38%-7.17M | 170.56%3.01M | 92.16%-542.49K | 89.97%-43.42M | -159.99%-27.71M | 98.93%-4.52M | 82.22%-4.27M | -127.88%-6.92M | -356.78%-432.74M | -179.10%-10.66M |
| Minority interest income | 59.39%1.62M | 528.53%3.37M | 89.95%-178.41K | 129.69%2.36M | -4.57%3.91M | 109.50%1.02M | 83.29%-787.4K | -152.45%-1.77M | -122.15%-7.96M | 911.37%4.09M |
| Net income attributable to the parent company | -58.57%-8.79M | 89.54%-364.05K | 92.93%-364.08K | 89.22%-45.79M | -114.33%-31.62M | 98.66%-5.54M | 81.96%-3.48M | -124.00%-5.15M | -420.36%-424.78M | -205.53%-14.75M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -58.57%-8.79M | 89.54%-364.05K | 92.93%-364.08K | 89.22%-45.79M | -114.33%-31.62M | 98.66%-5.54M | 81.96%-3.48M | -124.00%-5.15M | -420.36%-424.78M | -205.53%-14.75M |
| Basic earnings per share | -37.60%-1.72 | 91.14%-0.07 | 91.67%-1.5 | 89.55%-10.5 | -150.00%-7.5 | 98.66%-1.25 | 82.44%-0.79 | -460.25%-18 | -425.28%-100.5 | -192.10%-3 |
| Diluted earnings per share | -37.60%-1.72 | 91.14%-0.07 | 91.67%-1.5 | 89.55%-10.5 | -150.00%-7.5 | 98.66%-1.25 | 82.44%-0.79 | -460.25%-18 | -425.28%-100.5 | -192.10%-3 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data